434 related articles for article (PubMed ID: 8576151)
21. The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity.
Schnierer S; Kleine T; Gote T; Hillemann A; Knäuper V; Tschesche H
Biochem Biophys Res Commun; 1993 Mar; 191(2):319-26. PubMed ID: 8460992
[TBL] [Abstract][Full Text] [Related]
22. Production and purification of prostromelysin and procollagenase from IL-1 beta-stimulated human gingival fibroblasts.
Lark MW; Walakovits LA; Shah TK; Vanmiddlesworth J; Cameron PM; Lin TY
Connect Tissue Res; 1990; 25(1):49-65. PubMed ID: 2173990
[TBL] [Abstract][Full Text] [Related]
23. Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity.
Smith GN; Brandt KD; Hasty KA
Arthritis Rheum; 1996 Feb; 39(2):235-44. PubMed ID: 8849373
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.
Xia T; Akers K; Eisen AZ; Seltzer JL
Biochim Biophys Acta; 1996 Apr; 1293(2):259-66. PubMed ID: 8620038
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.
Aimes RT; Quigley JP
J Biol Chem; 1995 Mar; 270(11):5872-6. PubMed ID: 7890717
[TBL] [Abstract][Full Text] [Related]
26. Activation of human neutrophil procollagenase by stromelysin 2.
Knäuper V; Murphy G; Tschesche H
Eur J Biochem; 1996 Jan; 235(1-2):187-91. PubMed ID: 8631328
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of a high molecular weight type IV collagenase isolated from human carcinoma tissue.
Tsuda TT; Kodama A; Yamamura M; Matsuzaki S; Tsuda M
FEBS Lett; 1993 Mar; 319(1-2):35-9. PubMed ID: 8384126
[TBL] [Abstract][Full Text] [Related]
28. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes.
Murphy G; Cockett MI; Stephens PE; Smith BJ; Docherty AJ
Biochem J; 1987 Nov; 248(1):265-8. PubMed ID: 2829822
[TBL] [Abstract][Full Text] [Related]
29. Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex.
Brown PD; Kleiner DE; Unsworth EJ; Stetler-Stevenson WG
Kidney Int; 1993 Jan; 43(1):163-70. PubMed ID: 8433556
[TBL] [Abstract][Full Text] [Related]
30. Fragmentation of human polymorphonuclear-leucocyte collagenase.
Knäuper V; Osthues A; DeClerck YA; Langley KE; Bläser J; Tschesche H
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):847-54. PubMed ID: 8489511
[TBL] [Abstract][Full Text] [Related]
31. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.
Strongin AY; Marmer BL; Grant GA; Goldberg GI
J Biol Chem; 1993 Jul; 268(19):14033-9. PubMed ID: 8314771
[TBL] [Abstract][Full Text] [Related]
32. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3.
Nagase H; Suzuki K; Morodomi T; Enghild JJ; Salvesen G
Matrix Suppl; 1992; 1():237-44. PubMed ID: 1480033
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.
Neumann U; Kubota H; Frei K; Ganu V; Leppert D
Anal Biochem; 2004 May; 328(2):166-73. PubMed ID: 15113693
[TBL] [Abstract][Full Text] [Related]
34. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.
Knäuper V; Bailey L; Worley JR; Soloway P; Patterson ML; Murphy G
FEBS Lett; 2002 Dec; 532(1-2):127-30. PubMed ID: 12459476
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H
Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296
[TBL] [Abstract][Full Text] [Related]
36. Recombinant porcine collagenase: purification and autolysis.
Clark IM; Mitchell RE; Powell LK; Bigg HF; Cawston TE; O'Hare MC
Arch Biochem Biophys; 1995 Jan; 316(1):123-7. PubMed ID: 7840605
[TBL] [Abstract][Full Text] [Related]
37. An analysis of two refolding routes for a C-terminally truncated human collagenase-3 expressed in Escherichia coli.
Hardern IM; Knauper V; Ernill RJ; Taylor IW; Cooper KL; Abbott WM
Protein Expr Purif; 2000 Jul; 19(2):246-52. PubMed ID: 10873537
[TBL] [Abstract][Full Text] [Related]
38. The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin.
Mitchell TI; Jeffrey JJ; Palmiter RD; Brinckerhoff CE
Biochim Biophys Acta; 1993 Mar; 1156(3):245-54. PubMed ID: 8461313
[TBL] [Abstract][Full Text] [Related]
39. Substrate recognition by recombinant serine collagenase 1 from Uca pugilator.
Tsu CA; Craik CS
J Biol Chem; 1996 May; 271(19):11563-70. PubMed ID: 8626718
[TBL] [Abstract][Full Text] [Related]
40. Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase.
Verheijen JH; Nieuwenbroek NM; Beekman B; Hanemaaijer R; Verspaget HW; Ronday HK; Bakker AH
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):603-9. PubMed ID: 9169591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
